Treatment of acid maltase deficiency with a diet high in branched-chain amino acids.
Acid maltase deficiency in adults is associated with progressive muscle weakness and may effect respiratory muscles resulting in respiratory failure. The biochemical and clinical manifestations of acid maltase deficiency arise from a marked deficiency of the lysosomal enzyme alpha-glucosidase (acid maltase), which normally degrades glycogen to free glucose. In the past few years, high-protein diets have provided an alternative energy source for these patients and resulted in improved muscle strength. Recently, we treated a ventilator-dependent acid maltase-deficient patient with a general diet supplemented with branched-chain amino acids. Branched-chain amino acids are the principal amino acids involved in muscle protein synthesis and utilization. While on this diet, the patient had improvement of respiratory function and muscle strength and was able to be weaned from the ventilator during the day. In addition to his nutritional status, levels of serum branched-chain amino acids, showed improvement within 2 months after the diet started. This diet shows potential advantages over a high-protein diet without supplemented branched-chain amino acids for the treatment of acid maltase deficiency. These include theoretical sparing of amino acids required for muscle protein synthesis by providing higher concentrations of postprandial branched-chain amino acids in the circulation. Also, the liquid formula would be better tolerated by a ventilator-dependent or debilitated patient rather than a high-protein general diet. Further experience with branched-chain amino acid formulas will be needed to substantiate their efficacy in the treatment of acid maltase deficiency.
Mobarhan
S
S
Department of Medicine, University of Illinois, Chicago.
Pintozzi
R L
RL
Damle
P
P
Friedman
H
H
D000328:Adult; D000597:Amino Acids, Branched-Chain / Q000008:administration & dosage*; D004044:Dietary Proteins / Q000008:administration & dosage*; D004750:Enteral Nutrition / Q000379:methods*; D005526:Food, Formulated; D006009:Glycogen Storage Disease Type II / Q000628:therapy*; D006801:Humans; D008297:Male
D000597:Amino Acids, Branched-Chain; D004044:Dietary Proteins